A Response To: “cost-effectiveness of Oral Semaglutide Added to Current Antihyperglycemic Treatment for Type 2 Diabetes”
Year: 2021
Type: letter
Authors: Ciaran N Kohli-Lynch, Natalia Ruiz-Negrón, Amy Beal, Brandon K Bellows
Institutions: Northwestern University, University of Utah, Columbia University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3192576404